[The molecular mechanisms of intracellular TDP-43 aggregates]
- PMID: 19938686
[The molecular mechanisms of intracellular TDP-43 aggregates]
Abstract
TAR DNA binding protein of 43 kDa (TDP-43) was identified as a major component of the ubiquitin-positive inclusions found in frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). To investigate the molecular mechanisms underlying the formation of intracellular aggregates of TDP-43, we have established cellular models of intracellular TDP-43 aggregates similar to the pathological inclusions found in the brain FTLD and ALS patients. Deletion of the sequences near the nuclear localization signal resulted in cytoplasmic localization of TDP-43, whereas deletion mutants that lack the region around the RNA recognition motif localized in the nuclei, forming unique dot-like structures. Proteasome inhibition caused these structures to assemble into round aggregates that are reactive with anti-phosphorylated TDP-43 and anti-ubiquitin antibodies. Green fluorescent protein (GFP)-tagged N-terminal or C-terminal fragments of TDP-43 also promoted the formation of the abnormal intracellular inclusions. Co-expression of DsRed-tagged full-length TDP-43 with GFP-tagged C-terminal fragments of TDP-43 causes the formation of cytoplasmic inclusions that are positive for both GFP and DsRed. Cells with GFP and DsRed positive inclusions were nagative for normal nuclear staining for endogenous TDP-43. These results suggest that GFP-tagged C-terminal fragments of TDP-43 are bound not only to transfected DsRed-full-length TDP-43 but also to endogenous TDP-43. Endogenous TDP-43 may also be included in the cytoplasmic aggregates of TDP-43 C-terminal fragments, which results in the failure of its nuclear localization and therefore inhibits its function. We propose that the generation and aggregation of phosphorylated C-terminal fragments of TDP-43 play a primary role in the formation of inclusions, and the resultant loss of normal TDP-43 localization leads to neuronal degeneration in TDP-43 proteinopathy.
Similar articles
-
Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43.Hum Mol Genet. 2009 Sep 15;18(18):3353-64. doi: 10.1093/hmg/ddp275. Epub 2009 Jun 10. Hum Mol Genet. 2009. PMID: 19515851
-
Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.Neuropathology. 2010 Apr;30(2):170-81. doi: 10.1111/j.1440-1789.2009.01089.x. Epub 2010 Jan 19. Neuropathology. 2010. PMID: 20102522 Review.
-
Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells.FEBS Lett. 2009 Jan 22;583(2):394-400. doi: 10.1016/j.febslet.2008.12.031. Epub 2008 Dec 25. FEBS Lett. 2009. PMID: 19111550
-
[Intracellular seeded aggregation of TDP-43].Rinsho Shinkeigaku. 2012;52(11):1056-8. doi: 10.5692/clinicalneurol.52.1056. Rinsho Shinkeigaku. 2012. PMID: 23196514 Japanese.
-
[TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].Rinsho Shinkeigaku. 2009 Nov;49(11):783-5. doi: 10.5692/clinicalneurol.49.783. Rinsho Shinkeigaku. 2009. PMID: 20030209 Review. Japanese.
Cited by
-
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.Mol Neurobiol. 2019 Mar;56(3):2007-2021. doi: 10.1007/s12035-018-1218-2. Epub 2018 Jul 7. Mol Neurobiol. 2019. PMID: 29982983 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous